These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29059597)

  • 21. Is your ethics committee efficient? Using "IRB Metrics" as a self-assessment tool for continuous improvement at the Faculty of Tropical Medicine, Mahidol University, Thailand.
    Adams P; Kaewkungwal J; Limphattharacharoen C; Prakobtham S; Pengsaa K; Khusmith S
    PLoS One; 2014; 9(11):e113356. PubMed ID: 25406085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of institutional review board stipulations on turnaround time for approvals of surgical studies.
    Vazirani A; Castagne-Charlotin M; Akpoviroro O; Malikova MA
    World J Surg; 2024 Feb; 48(2):271-277. PubMed ID: 38310311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Institutional Review Board Quality, Private Equity, and Promoting Ethical Human Subjects Research.
    Lynch HF; Rosenfeld S
    Ann Intern Med; 2020 Oct; 173(7):558-562. PubMed ID: 32687743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Too Many Rationales, Not Enough Reason: A Call to Examine the Goals of Including Lay Members on Institutional Review Boards.
    Solomon S
    Account Res; 2016; 23(1):4-22. PubMed ID: 26528638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Impact of Institutional Review Boards (IRBs) on Clinical Innovation: A Survey of Investigators and IRB Members.
    Stryjewski TP; Kalish BT; Silverman B; Lehmann LS
    J Empir Res Hum Res Ethics; 2015 Dec; 10(5):481-7. PubMed ID: 26564945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IRBs and the Protection-Inclusion Dilemma: Finding a Balance.
    Friesen P; Gelinas L; Kirby A; Strauss DH; Bierer BE
    Am J Bioeth; 2023 Jun; 23(6):75-88. PubMed ID: 35482887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethical review of research involving human subjects: when and why is IRB review necessary?
    Wagner RM
    Muscle Nerve; 2003 Jul; 28(1):27-39. PubMed ID: 12811770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Institutional Review Board Use of Outside Experts: What Do We Know?
    Serpico K; Rahimzadeh V; Anderson EE; Gelinas L; Lynch HF
    Ethics Hum Res; 2022 Mar; 44(2):26-32. PubMed ID: 35218600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health service research: the square peg in human subjects protection regulations.
    Gittner LS; Roach MJ; Kikano G; Grey S; Dawson NV
    J Med Ethics; 2011 Feb; 37(2):118-22. PubMed ID: 21071571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The institutional review board as a mirror of scientific and ethical standards.
    Rosnow RL; Rotheram-Borus MJ; Ceci SJ; Blanck PD; Koocher GP
    Am Psychol; 1993 Jul; 48(7):821-6. PubMed ID: 8357107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethics Review for a Multi-Site Project Involving Tribal Nations in the Northern Plains.
    Angal J; Petersen JM; Tobacco D; Elliott AJ;
    J Empir Res Hum Res Ethics; 2016 Apr; 11(2):91-6. PubMed ID: 26928897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computerized information management for institutional review boards.
    Hood MN; Gugerty B; Levine R; Ho VB
    Comput Inform Nurs; 2005; 23(4):190-8; quiz 199-200. PubMed ID: 16027533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measuring inconsistency in research ethics committee review.
    Trace S; Kolstoe SE
    BMC Med Ethics; 2017 Nov; 18(1):65. PubMed ID: 29179709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Of Parachutes and Participant Protection: Moving Beyond Quality to Advance Effective Research Ethics Oversight.
    Lynch HF; Nicholls S; Meyer MN; Taylor HA;
    J Empir Res Hum Res Ethics; 2019 Jul; 14(3):190-196. PubMed ID: 30541368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Institutional review board guidance on pediatric research: missed opportunities.
    Wolf LE; Zandecki J; Lo B
    J Pediatr; 2005 Jul; 147(1):84-9. PubMed ID: 16027701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should society allow research ethics boards to be run as for-profit enterprises?
    Emanuel EJ; Lemmens T; Elliot C
    PLoS Med; 2006 Jul; 3(7):e309. PubMed ID: 16848618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current status of the institutional review boards in Korea: constitution, operation, and policy for protection of human research participants.
    Kim OJ; Park BJ; Sohn DR; Lee SM; Shin SG
    J Korean Med Sci; 2003 Feb; 18(1):3-10. PubMed ID: 12589079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of warning letters issued by the US Food and Drug Administration to clinical investigators, institutional review boards and sponsors: a retrospective study.
    Shetty YC; Saiyed AA
    J Med Ethics; 2015 May; 41(5):398-403. PubMed ID: 24965716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Why Public Comments Matter: The Case of the National Institutes of Health Policy on Single Institutional Review Board Review of Multicenter Studies.
    Ervin AM; Taylor HA; Ehrhardt S; Meinert CL
    Acad Med; 2018 Aug; 93(8):1157-1161. PubMed ID: 29517531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The challenges of IRB review and human subjects protections in practice-based research.
    Wolf LE; Croughan M; Lo B
    Med Care; 2002 Jun; 40(6):521-9. PubMed ID: 12021678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.